Scholars Central

Research articlePublished 1 Oct 2016

Anticancer evaluation of novel 1,3,4-trisubstituted pyrazole candidates bearing different nitrogenous heterocyclic Moieties

Authors: Magda M. F. Ismail, Nagy M. Khalifa, Hoda H. Fahmy, Hend M. EL-Sahrawy, Eman S. Nossier

Biomedical Research

Volume 27 · Issue 4 · Pages 1087–1093

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

With the goal of developing novel and potent anticancer therapies, a new set of 1,3,4-trisubstituted pyrazole derivatives linked to different heteroaryl systems at C-4 position were prepared and estimated for their anticancer effects at NCI, USA employing a two stage procedure using 60 various human tumor cell lines. Anticancer evaluation disclosed that, compound 4c displayed super fat potency towards most human tumor cell lines with GI50 (0.52-5.15 μM), particularly against colon SW-620 cell line with GI50 (0.52 μM). At the same time, 4c was also selective against A498 and RXF 393 cell lines of renal cancer with GI50 0.58 and 0.86 μM respectively.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Magda M. F. Ismail”
  • BylineArticles whose byline prints “Nagy M. Khalifa”
  • BylineArticles whose byline prints “Hoda H. Fahmy”
  • BylineArticles whose byline prints “Hend M. EL-Sahrawy”
  • BylineArticles whose byline prints “Eman S. Nossier”